Digital Health Startups

Evinature develops plant-based nutraceutical formulations, including CurQD, aimed at gut health and conditions related to gut integrity, backed by clinical trials. It offers a personalized care program combining clinically-validated compounds with monthly check-ups, a personal representative, and direct delivery to consumers.

1 investor

Evision Academy provides professional development training and curriculum solutions for teaching braille and serving visually impaired students. The company offers braille learning kits, teacher reporting software, assessments, and activities to support educators in delivering inclusive instruction.

1 investor

evismo provides diagnostic services using sensor technology to detect cardiac arrhythmias, stress, and sleep apnea for general practitioners and specialists.

1 investor

Evogenom provides at-home DNA testing kits that analyze wellness-related genetic variants to deliver personalized insights on nutrition, fitness, sleep, and stress management. The company pairs genetic analysis with an AI coach to translate individual biology into actionable daily routines and health recommendations.

1 investor

Evoke Health develops a resident and family portal for long-term care homes to provide secure access to health data and communication with care teams. The platform aims to improve care coordination and compliance for healthcare facilities and families.

1 investor

Evolution Healthcare operates a network of private hospitals and specialist day facilities in New Zealand providing surgical, maternity, and healthcare services. The group delivers comprehensive healthcare and wellbeing services through hospitals and specialist practitioners.

1 investor

ExAI develops technology for early cancer detection, diagnosis, and management. The company serves healthcare providers and patients in the oncology space.

1 investor

Exalt Health is a post-acute care healthcare organization that operates hospitals and care facilities based on an operational model focused on efficiency and clinical outcomes. The company serves patients requiring rehabilitation, long-term acute care, and skilled nursing services.

1 investor

ExamWorks provides independent medical examinations, peer and medical record reviews, and bill review services for healthcare organizations and disability claims administrators. The company operates a platform with workflow tools and portals to manage these services at scale.

1 investor

Excel Health Primary Care is a primary care medical practice based in Atlanta. The company provides primary care services to patients.

1 investor

ExerWatch develops a wearable sensor and companion app that uses AI to learn a patient's prescribed rehabilitation exercise and give real-time feedback on whether each repetition is performed correctly, while sending adherence and technique reports to physiotherapists between visits. The pre-launch product targets physios and rehab patients, and originated from University of Melbourne research.

1 investor

Eximia Research operates a nationwide clinical research network that conducts clinical trials, managing patient recruitment, enrollment, and trial operations on behalf of pharmaceutical sponsors and CRO partners. Its sites are overseen by board-certified physician investigators who run regulated studies evaluating new treatments.

1 investor

Exin Health builds ORGenie, a software layer for ambulatory surgery centers (ASCs) that integrates existing EHR, inventory, and scheduling systems to coordinate staff, rooms, supplies, and financials. The platform uses voice and vision AI to automate clinical documentation and surface operational and financial insights.

1 investor

ExMedio provides an IT platform called Hipokura that enables physicians across specialties to share clinical knowledge, seek specialist consultations, and discuss cases to improve diagnostic and treatment quality. The platform serves doctors in Japan with over 70,000 registered physicians and includes specialized consultation features for dermatology, ophthalmology, cardiology, pulmonology, and rare diseases.

1 investor

ExOcular develops blood-based multiplex tests that measure biomarkers isolated from exosomes to detect and monitor severe eye diseases such as diabetic retinopathy and age-related macular degeneration. Its analysis algorithms produce a quantitative Disease Severity Score to help physicians risk-stratify patients and track treatment effectiveness.

1 investor

Exogenus develops therapeutic exosomes derived from umbilical cord blood cells to treat autoimmune diseases through immune system rebalancing. The company targets multiple autoimmune disease indications where existing pharmaceutical treatments carry significant side effects.

1 investor

Experity develops software and AI-driven operational technology for on-demand and urgent care healthcare providers, supporting clinical operations, electronic medical records, and patient experience. It serves urgent care clinics and on-demand healthcare operators, positioning itself as an operating system for the sector.

1 investor

Voxia is a wearable control interface that converts intentional vocal cord activation, such as a hum, into real-time input, allowing people with severe motor and speech impairments (e.g. ALS, stroke, cerebral palsy, Parkinson's) to operate AAC software, computers, tablets, and smart home devices. It is a medical device in development targeting Health Canada and US FDA clearance, aimed at patients who have exhausted conventional access technologies.</parameter> <parameter name="hq_country">CA

1 investor

EXPIN develops AI-driven tools for clinicians to analyze exposome data—the lifetime accumulation of environmental, chemical, and lifestyle exposures—to enable precision medicine for chronic disease prevention and treatment. The company serves healthcare providers and patients seeking to understand how non-genetic factors drive disease at the molecular level.

1 investor

ExpiWell provides ecological momentary assessment (EMA) and experience sampling (ESM) software used by researchers to capture real-time data on participants' daily experiences, emotions, and behaviors. The platform enables peer-reviewed research across psychology, medicine, organizational behavior, and ESM methodology.

1 investor

Exprimary develops bioanalytical instrumentation and assay products at reduced cost for research and diagnostic markets. The company focuses on enabling personalized healthcare by improving access to bioanalysis tools globally.

1 investor

Eyconis is a clinical-stage biotechnology company developing long-acting ophthalmic therapies for serious eye diseases such as wet age-related macular degeneration and diabetic macular edema using the TransCon technology platform. The company aims to reduce treatment burden for patients by extending the duration between required injections while improving disease control and visual outcomes.

1 investor

EyeCheckup is an AI-powered eye scanning system that diagnoses retinal diseases, cardiovascular disease, and chronic kidney disease from retinal fundus images. The company serves eye clinics, hospitals, health centers, and aims to increase screening access for the billions of people worldwide who need annual eye exams.

1 investor

EyeBuddy develops AI tools for early detection of eye diseases that work alongside clinicians in hospitals and eye care facilities. The company serves ophthalmologists and healthcare providers in Canada, South Asia, and the UK, with a focus on making eye care accessible to underserved populations.

1 investor